Events & Presentations

Five Prime Therapeutics Research & Development Day
Thursday, December 8, 2016
8:00 AM ET
Location: New York City, NY

Five Prime will give in-depth presentations covering:

  • An introduction of therapeutic candidates in IND-enabling activities, including:
    • a tetravalent GITR agonist antibody
    • a T cell modulator
    • and an additional multi-functional immune modulator
  • An in-depth overview of the company's unique preclinical immuno-oncology discovery platform and screening progress
  • A status update on clinical development programs

Planned presenters include senior executives from Five Prime's scientific, clinical and management team as well as featured guest speakers:

  • Drew M. Pardoll, M.D., Ph.D., Abeloff Professor of Oncology, Johns Hopkins University, School of Medicine, Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Director, Cancer Immunology Program at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
     
  • Daniel Catenacci, M.D., Assistant Professor, University of Chicago,  Associate Director, Gastrointestinal Oncology Program
     
  • Robert Albert Anders, M.D., Ph.D., Associate Professor of Pathology, Johns Hopkins University School of Medicine
     
  • Nils Lonberg, Ph.D., Senior Vice President, Biologics Discovery, Bristol-Myers Squibb

For additional information, please email amy.kendall@fiveprime.com.

PDF View Presentation   22.1 MB   Add to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
28.95
Change (%)
0.00
Volume
N/A

Data as of 4:00 PM ET on Friday, May 26, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.